Published in
American Association for the Advancement of Science, Science Translational Medicine, 439(10), 2018
DOI: 10.1126/scitranslmed.aar2036
Links
Tools
Development of a stress response therapy targeting aggressive prostate cancer
Journal article published in 2018 by
Hao G. Nguyen 
,
Crystal S. Conn ,
Yae Kye ,
Lingru Xue ,
Craig M. Forester ,
Janet E. Cowan ,
Andrew C. Hsieh ,
John T. Cunningham ,
Charles Truillet ,
Feven Tameire ,
Michael J. Evans ,
Christopher P. Evans ,
Joy C. Yang,
Byron Hann ,
Constantinos Koumenis
and other authors.
,
Crystal S. Conn ,
Yae Kye ,
Lingru Xue ,
Craig M. Forester ,
Janet E. Cowan ,
Andrew C. Hsieh ,
John T. Cunningham ,
Charles Truillet ,
Feven Tameire ,
Michael J. Evans ,
Christopher P. Evans ,
Joy C. Yang,
Byron Hann ,
Constantinos Koumenis
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
The PERK-eIF2α pathway is activated in aggressive prostate cancer and associated with patient outcome, providing a therapeutic target for the disease.